Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gvoke vs Lilly Glucagon for Hypoglycemia Rescue in T1DM
NCT02656069Phase 3Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- Mar 2017
- Primary completion
- Aug 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of G-Pen in hypoglycemia, sponsored by Xeris Biopharma Holdings, Inc.. Started Mar 2017; status: completed.
02
Drugs
G-Pen
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02656069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656069.